Start of Day Message
June 10, 2024 01:00 ET
|
GlobeNewswire, Inc.
LONDON, 10 Jun. 2024 (GLOBE NEWSWIRE) -- This is the Start of Day Message for GlobeNewswire. GlobeNewswire is operated by Notified and is designated by the FCA as an approved primary information...
Start of Day Message
June 10, 2024 01:00 ET
|
GlobeNewswire, Inc.
LONDON, 10 Jun. 2024 (GLOBE NEWSWIRE) -- This is the Start of Day Message for GlobeNewswire. GlobeNewswire is operated by Notified and is designated by the FCA as an approved primary information...
Santhera Announces Launch of Early Access Program in China for AGAMREE® by its Partner Sperogenix
June 10, 2024 01:00 ET
|
Santhera Pharmaceuticals Holding AG
Pratteln, Switzerland, June 10, 2024 – Santhera Pharmaceuticals (SIX: SANN) announces that its partner Sperogenix Therapeutics has launched a paid-for Early Access Program (EAP) for AGAMREE®...
Corbion reports the progress of its € 20 million share buyback program 3 June – 7 June 2024
June 10, 2024 01:00 ET
|
Corbion
Corbion hereby reports the transaction details related to its € 20 million share buyback program announced on 26 April 2024. During the week of 3 June up to and including 7 June 2024 a total of...
IMCD Italy expands its Pharmaceuticals presence with the acquisition of Selechimica
June 10, 2024 01:00 ET
|
IMCD N.V.
ROTTERDAM, The Netherlands (10 June 2024) – IMCD N.V. (“IMCD” or “Company”), a leading distributor of speciality chemicals and ingredients, today announces that IMCD Italy has signed an agreement to...
Press release Biocartis NV: Biocartis Welcomes Gina Wallar, PhD as Chief Business Officer and Judith Vacchino, PhD as VP Global Marketing
June 10, 2024 01:00 ET
|
Biocartis NV
PRESS RELEASE - 10/06/2024, 07:00 CEST Biocartis Welcomes Gina Wallar, PhD as Chief Business Officer and Judith Vacchino, PhD as VP Global Marketing Mechelen, Belgium 10 June 2024 – Biocartis NV...
European Commission approves Roche’s Alecensa as the first and only targeted adjuvant treatment for people with ALK-positive early-stage lung cancer
June 10, 2024 01:00 ET
|
F. Hoffmann-La Roche Ltd
European Commission approves Roche’s Alecensa as the first and only targeted adjuvant treatment for people with ALK-positive early-stage lung cancer Alecensa reduced the risk of disease...
Food Logistics Names Covenant Logistics Group as Recipient of 2024 Top 3PL & Cold Storage Providers Award
June 10, 2024 00:05 ET
|
Covenant Logistics Group, Inc.
CHATTANOOGA, Tenn., June 10, 2024 (GLOBE NEWSWIRE) -- Food Logistics named Covenant Logistics Group as one of the winners of this year’s Top 3PL & Cold Storage Providers Award, which recognizes...
Griffin Global Asset Management Extends and Upsizes Senior Unsecured Revolving Credit Facility to $1.2 Billion
June 10, 2024 00:01 ET
|
Griffin Global Asset Management
DUBLIN, June 10, 2024 (GLOBE NEWSWIRE) -- Griffin Global Asset Management Holdings, Ltd. (“Griffin Corporate”) is pleased to announce that, as of June 6, 2024, it has increased the amount available...
Hepsor's Canadian subsidiary made its third investment in the Canadian real estate market
June 10, 2024 00:00 ET
|
HEPSOR AS
Hepsor SPV I Ltd, a Ontario-based subsidiary of Hepsor AS, made its third investment in the Canadian real estate market. An assembly of 7 properties was acquired in the much desired midtown...
- June 09, 2024 09:02 ET Optimove Insights Releases the 2024 Consumer Summer Shopping Report
- June 08, 2024 17:09 ET Stockholder Alert: Robbins LLP Informs Investors of the Class Action Lawsuit Filed Against The Scotts Miracle-Gro Company